Bio-Path Holdings Inc
BPTH
BPTH was delisted on the 18th of February, 2025.
21 hedge funds and large institutions have $257K invested in Bio-Path Holdings Inc in 2023 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 3 closing their positions.
150% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 2
100% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 3
17% more funds holding
Funds holding: 18 → 21 (+3)
68% less capital invested
Capital invested by funds: $812K → $257K (-$555K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Walleye Capital
New York
|
+$145K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$18.8K |
| 3 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
+$16.7K |
| 4 |
Millennium Management
New York
|
+$12.9K |
| 5 |
HF
HRT Financial
New York
|
+$12.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$60.4K |
| 2 |
MYIA
Mount Yale Investment Advisors
Denver,
Colorado
|
-$45.1K |
| 3 |
VF
Virtu Financial
New York
|
-$21K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$2.15K |
| 5 |
JP Morgan Chase
New York
|
-$306 |
BPTH Hedge Fund Activity: Q3 2023 in Review
21 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in Bio-Path Holdings Inc (BPTH) for Q3 2023, worth a combined $257K — down 68% from $812K a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new BPTH positions and 3 closed out — a net gain of 3 holders — while 5 added to existing stakes and 2 trimmed.
The largest buyer was Walleye Capital, opening a new position worth an estimated $145K. The largest seller was Vanguard Group, cutting an estimated $60.4K.
- 21 institutional investors held Bio-Path Holdings Inc (BPTH) as of Q3 2023, up from 18 in Q2 2023.
- Funds reported $257K of Bio-Path Holdings Inc stock for Q3 2023, down 68% quarter-over-quarter.
- 6 funds opened new Bio-Path Holdings Inc positions in Q3 2023 and 3 closed out, a net change of +3 holders.
- The largest Bio-Path Holdings Inc buyer in Q3 2023 was Walleye Capital, an estimated $145K added.
- The largest Bio-Path Holdings Inc seller in Q3 2023 was Vanguard Group, an estimated $60.4K sold.
Based on aggregated 13F filings for Q3 2023.